loadpatents
name:-0.034801959991455
name:-0.013427972793579
name:-0.0012309551239014
Fuhrmann; Ulrike Patent Filings

Fuhrmann; Ulrike

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fuhrmann; Ulrike.The latest application filed is for "intrauterine delivery system for contraception".

Company Profile
0.13.28
  • Fuhrmann; Ulrike - Berlin DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Intrauterine delivery system for contraception
Grant 10,532,025 - Duesterberg , et al. Ja
2020-01-14
Intrauterine Delivery System For Contraception
App 20180263899 - Duesterberg; Bernd ;   et al.
2018-09-20
Intrauterine delivery system for contraception
Grant 9,999,592 - Duesterberg , et al. June 19, 2
2018-06-19
Method Of Contraception
App 20170312219 - Duesterberg; Bernd ;   et al.
2017-11-02
Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
Grant 9,655,887 - Lindenthal , et al. May 23, 2
2017-05-23
Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception
Grant 9,579,330 - Lindenthal , et al. February 28, 2
2017-02-28
Intrauterine Delivery System
App 20160262923 - AHOLA; Manja ;   et al.
2016-09-15
Pharmaceutical Composition And The Use Thereof, And Application Regime Of Said Pharmaceutical Composition For On-demand Contraception
App 20160089364 - LlNDENTHAL; Bernhard ;   et al.
2016-03-31
Use And Application Regimen Of A Pharmaceutical Composition Containing Levonorgestrel And A Cox Inhibitor For On-demand Contraception
App 20160000805 - LINDENTHAL; Bernhard ;   et al.
2016-01-07
18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
Grant 8,445,469 - Bohlmann , et al. May 21, 2
2013-05-21
Progesterone receptor antagonists
Grant 8,053,426 - Fuhrmann , et al. November 8, 2
2011-11-08
Sequential administration of 20,20,21,21,21-pentafluoro-17-hydroxy-11Beta-[4-(hydroxyacetyl)phenyl]-19- -nor-17Alpha-pregna-4,9-dien-3-one and one or more progestogens for the treatment of gynaecological disorders
App 20110112057 - Fuhrmann; Ulrike ;   et al.
2011-05-12
Mineralcorticoid Receptor Antagonists For The Treatment Of Endometriosis
App 20110003778 - Moeller; Carsten ;   et al.
2011-01-06
Non-steroidal Progesterone Receptor Modulators
App 20090099147 - SCHWEDE; Wolfgnag ;   et al.
2009-04-16
Non-steroidal Progesterone Receptor Modulators
App 20090075989 - Schwede; Wolfgang ;   et al.
2009-03-19
18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, As Well As Pharmaceutical Preparations That Contain The Latter
App 20090029953 - Bohlmann; Rolf ;   et al.
2009-01-29
Progesterone receptor antagonists
App 20080200440 - Fuhrmann; Ulrike ;   et al.
2008-08-21
Non-steroidal Progesterone Receptor Modulators
App 20080188448 - Schwede; Wolfgang ;   et al.
2008-08-07
Nonsteroidal progesterone receptor modulators
Grant 7,408,060 - Schmees , et al. August 5, 2
2008-08-05
Non-steroidal progesting
Grant 7,388,006 - Schmees , et al. June 17, 2
2008-06-17
Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
Grant 7,378,406 - Hoffmann , et al. May 27, 2
2008-05-27
Composition Comprising Antiprogestins And Pure Antiestrogens For Prophylaxis And Treatment Of Hormone-dependent Diseases
App 20070238714 - FUHRMANN; Ulrike ;   et al.
2007-10-11
Nonsteroidal progesterone receptor modulators
App 20070142464 - Schmees; Norbert ;   et al.
2007-06-21
Non-steroidal progesterone receptor modulators
App 20070010514 - Bothe; Ulrich ;   et al.
2007-01-11
Use of non-steroidal progesterone receptor modulators
App 20060293317 - Schmees; Norbert ;   et al.
2006-12-28
Antigestagenically active steroids with a fluorinated 17.alpha.-alkyl chain
Grant 7,148,213 - Schwede , et al. December 12, 2
2006-12-12
18-Methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
App 20060252737 - Bohlmann; Rolf ;   et al.
2006-11-09
Antigestagenically active steroids with a fluorinated 17alpha-alkyl chain
App 20050080060 - Schwede, Wolfgang ;   et al.
2005-04-14
Composition comprising progesterone-receptor antagonists and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
App 20050014736 - Fuhrmann, Ulrike ;   et al.
2005-01-20
Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
App 20040242551 - Fuhrmann, Ulrike ;   et al.
2004-12-02
Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain
Grant 6,806,263 - Schwede , et al. October 19, 2
2004-10-19
Inhibition of the growth factor dependency of tumor cells
App 20040157811 - Lichtner, Rosemarie ;   et al.
2004-08-12
Method for screening for progesterone receptor isoform-specific ligands and for tissue-selective progesterone receptor ligands
App 20040121304 - Fuhrmann, Ulrike ;   et al.
2004-06-24
Use of antiprogestins for the induction of apoptosis in a cell
App 20040072811 - Hoffmann, Jens ;   et al.
2004-04-15
Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
App 20040048841 - Hoffmann, Jens ;   et al.
2004-03-11
Non-steroidal progesting
App 20030232824 - Schmees, Norbert ;   et al.
2003-12-18
Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain
App 20030134834 - Schwede, Wolfgang ;   et al.
2003-07-17
Use and compositions of antiprogestins for treatment of prostate diseases
App 20030013694 - Hoffmann, Jens ;   et al.
2003-01-16
Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain
App 20020045774 - Schwede, Wolfgang ;   et al.
2002-04-18
Antigestagenically active steroids with a flourinated 17 .alpha.-alkyl chain
Grant 6,316,432 - Schwede , et al. November 13, 2
2001-11-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed